Based on the GeneDx Holdings Corp. stock forecast from 6 analysts, the average analyst target price for GeneDx Holdings Corp. is USD 43.55 over the next 12 months. GeneDx Holdings Corp.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of GeneDx Holdings Corp. is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, GeneDx Holdings Corp.’s stock price was USD 78.71. GeneDx Holdings Corp.’s stock price has changed by +15.02% over the past week, +40.35% over the past month and +5,482.27% over the last year.
No recent analyst target price found for GeneDx Holdings Corp.
No recent average analyst rating found for GeneDx Holdings Corp.
Company Overview GeneDx Holdings Corp.
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. Read Less
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and syn...Read More
Frequently Asked Questions About GeneDx Holdings Corp. (WGS) Stock
Based on ratings from 6 analysts GeneDx Holdings Corp.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 7 buy, sell and 4 hold ratings.
Unfortunately we do not have enough data on WGS's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for WGS is USD 43.55 over the next 12 months. The maximum analyst target price is USD 75 while the minimum anlayst target price is USD 21.
WGS stock's Price/Earning ratio is 1.83.
Our analysis grades WGS stock's Price / Earning ratio at B+. This means that WGS stock's Price/Earning ratio is above 11% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this WGS may be undervalued for its sector.
The last closing price of WGS's stock was USD 78.71.
The most recent market capitalization for WGS is USD 1.91B.
Based on targets from 6 analysts, the average taret price for WGS is projected at USD 43.55 over the next 12 months.
This means that WGS's stock price may go down by -44.68% over the next 12 months.
We can't find any ETFs which contains GeneDx Holdings Corp.'s stock.
As per our most recent records GeneDx Holdings Corp. has 1,000 Employees.
GeneDx Holdings Corp.'s registered address is North Tower, Stamford, CT, United States, 06902.
You can get more information about it from GeneDx Holdings Corp.'s website at https://www.genedx.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About GeneDx Holdings Corp. (WGS) Stock
Based on ratings from 6 analysts GeneDx Holdings Corp.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 7 buy, sell and 4 hold ratings.
Unfortunately we do not have enough data on WGS's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for WGS is USD 43.55 over the next 12 months. The maximum analyst target price is USD 75 while the minimum anlayst target price is USD 21.
WGS stock's Price/Earning ratio is 1.83.
Our analysis grades WGS stock's Price / Earning ratio at B+. This means that WGS stock's Price/Earning ratio is above 11% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this WGS may be undervalued for its sector.
The last closing price of WGS's stock was USD 78.71.
The most recent market capitalization for WGS is USD 1.91B.
Based on targets from 6 analysts, the average taret price for WGS is projected at USD 43.55 over the next 12 months.
This means that WGS's stock price may go down by -44.68% over the next 12 months.
We can't find any ETFs which contains GeneDx Holdings Corp.'s stock.
As per our most recent records GeneDx Holdings Corp. has 1,000 Employees.
GeneDx Holdings Corp.'s registered address is North Tower, Stamford, CT, United States, 06902.
You can get more information about it from GeneDx Holdings Corp.'s website at https://www.genedx.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for WGS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
